Tag: Home Infusion

FRISCO, Texas – Soleo Health, a national provider of complex specialty pharmacy services, has been selected by Eisai Inc., a developer of pharmaceuticals, as the sole specialty pharmacy distribution partner for LEQEMBI, which was recently approved by the U.S. Food & Drug Administration for the treatment of Alzheimer’s disease. LEQEMBI is an anti-amyloid monoclonal antibody used to treat mild cognitive impairment due to Alzheimer’s and mild or early Alzheimer’s disease (collectively...

DALLAS – Medix Infusion has closed a $35 million Series B funding round led by Echo Health Ventures. Additional participants included Pittco Direct Investments II, the direct investing arm of Pittco Management, LLC, and initial investor Noro-Moseley Partners. The company will use its newly secured investment to support organic growth and acquire the infusion operations of the Center for Neurology and Spine, a national leader in the treatment of neurological disorders that serves patients across...

WASHINGTON – CMS plans to primarily focus MAC, RAC and SMRC medical reviews on claims with dates of service outside of the public health emergency, the agency stated in a recent clarification.  CMS stated:  “During the PHE, flexibilities were applied across claim types. For certain DME items, this included the non-enforcement of clinical indications for coverage. Since clinical indications for coverage were not enforced for certain DME items provided during the PHE, once...

WASHINGTON – CMS has announced an 8.7% payment increase for home infusion therapy for calendar year 2023.  The payment is based on the percent increase in the Consumer Price Index for all urban customers (CPI-U) for the 12-month period ending with June of the preceding year (9.1%), reduced by the productivity adjustment for CY 2023 (0.4%).  “The single payment amounts are also adjusted in a budget neutral manner using standardization factors for geographic area wage differences...

ASHLAND, Ky. – The board of directors of Infusion Solutions, which provides home infusion therapy to patients from two locations in Ashland, Ky., and Charleston, West Va., has agreed to dissolve the company, according to the Daily Independent. The company is owned equally by St. Mary’s Medical Center, Charleston Area Medical Center and St. Claire HealthCare. “This was an extremely difficult decision for the board and one we do not take lightly,” said David Sheils, Infusion...

WASHINGTON – A diverse group of 30 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services.   In an Oct. 31 letter, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 2652/H.R. 5067) to increase access to home infusion therapy for Medicare beneficiaries.   “Home infusion therapy services have been a lifeline for millions of Americans by delivering lifesaving...

FRISCO, Texas, and LOS ANGELES – Soleo Health has announced that its Los Angeles pharmacy location has earned specialty pharmacy accreditation from URAC. By achieving accreditation, the company says it continues to demonstrate its commitment to quality patient-centric care, patient safety, exceptional therapy management programs and improved outcomes. "The Soleo Health Los Angeles URAC accreditations validate the levels of high-quality care and service we bring to patients throughout California,”...

MIRAMAR, Fla. – Integrated Home Care Services, an independent administrator of home health, DME and home infusion benefits, has announced that its MedTrac Home Insights and Outcomes Platform has received the silver award for the Home Care Innovator of the Year as part of the 2022 McKnight’s Excellence in Technology Awards program. The annual program celebrates outstanding innovation by skilled nursing, senior living and home care providers. "We developed MedTrac to better support our...

MURFREESBORO, Tenn. – TwelveStone Health Partners has announced that its TwelveStone Infusion Support CON application was approved on Sept. 28 for 90 counties in Tennessee. The CON allows the company to provide nursing care for their patients when other home health options aren’t available. "Obtaining this CON further equips TwelveStone to deliver on the promise of a positive and convenient experience for patients who need a higher-level of care," says Shane Reeves, CEO, TwelveStone Health...

FRISCO, Texas – Soleo Health has added AMVUTTRA (vutrisiran) to its specialty pharmacy portfolio to treat adults with the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. Soleo Health offers newly FDA-approved AMVUTTRA injections to patients in their homes (after an evaluation and recommendation by the treating physician) or at one of its ambulatory infusion centers (AICs) nationwide. “This marks the fourth therapy Soleo Health now offers from Alnylam Pharmaceuticals’...